CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results from booster trial

CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results from booster trial
·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups should be eligible for the boosters developed by Moderna and Johnson & Johnson.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting